Bavarian Nordic discloses share buyback transactions
The company bought 94,500 shares between September 28 and October 2 at an average price of DKK 217.46, holding 5.21% of capital.
Latest Bavarian Nordic News & Updates
See the latest news and media coverage for Bavarian Nordic. We track all announcements, press releases, and industry mentions in real time, all in one place.
Vaccine research, development and manufacturing company
bavarian-nordic.com- Headquarters
- Copenhagen, Denmark
- Founded year
- 1994
- Company type
- Public company
- Number of employees
- 1,800–5,000
- Industry
- Pharmaceuticals
Last updated
Latest news about Bavarian Nordic
In short: Bavarian Nordic upgraded 2026 guidance, appointed a new CEO, and expanded mpox and chikungunya vaccine access.
Company announcements
Bavarian Nordic appoints Tarja Stenvall as CEO
She brings over 20 years of pharma experience and starts October 15, 2026.
Bavarian Nordic reports strong H1 2026 results
CEO Paul Chaplin reflects on growth, progress, and teamwork in a video review of the company's first half performance.
Bavarian Nordic initiates a DKK 750 million share repurchase program
The company plans to cancel bought shares and close its unutilized DKK one billion credit line to optimize capital allocation for future acquisitions.
Media coverage
Bavarian Nordic: The long-term potential exceeded the private equity firms' 'discount'
It now seems that ATP and the private investors were right to say no to the purchase offer from the private equity firms Nordic Capital and Permira...
Bavarian Nordic expects increased sales of travel vaccines | Business | Berlingske
The Danish vaccine company Bavarian Nordic sees rising demand for rabies vaccines in particular.
SHAREHOLDER tip Bavarian Nordic surprises again - stock takes off
The European vaccine developer and manufacturer has good news for shareholders on Thursday once again. Bavarian Nordic is once again optimistic about the current fiscal year...
Bavarian Nordics new CEO starts with a tailwind
Sustained tailwinds to the monkeypox business now have Bavarian lifting its long-term expectation for this part of the business...
Never miss news about Bavarian Nordic
Track Bavarian Nordic and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Bavarian Nordic competitors & trending companies
Browse news for competitors to Bavarian Nordic and other trending companies.
AstraZeneca
Merck
Pfizer
Moderna
BioNTech
GSK
MSD
Sanofi
Emergent
Zydus
Novavax
Vaxcyte
SharkNinja
NRx
Ropes & Gray
HighTech Kaunas
inretrn
Poundland
Farrer & Co
Specialfastigheter
SISAB
Hemsö
Stenvalvet
Liljewall
Veidekke
Locum
NCC
Kriminalvården
Archus
Nyréns
Peab
MVB
VGR fastigheter
AIX
ByggDialog
Tengbom